Stocks › HIMS

Hims & Hers Health, Inc.

HIMS·NYSE·United States United States·USD
$14.60
-1.42 (-8.86%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
HIMS
Hims & Hers Health, Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HIMSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of HIMS by members of U.S. Congress · 5 on record · 2 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Tony WiedTony WiedHouse · R · WI HIMSHims & Hers Health, Inc. · Stock Purchase
$50,001 - $100,000
Mar 9, 2026 Feb 3, 2026 Filing ↗
Tony WiedTony WiedHouse · R · WI HIMSHims & Hers Health, Inc. · Stock Sale
$100,001 - $250,000
Jan 9, 2026 Dec 17, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI HIMSHims & Hers Health, Inc. · Stock Purchase
$1,001 - $15,000
Sep 12, 2025 Aug 4, 2025 Filing ↗
Tony WiedTony WiedHouse · R · WI HIMSHims & Hers Health, Inc. · Stock Purchase
$100,001 - $250,000
Mar 14, 2025 Feb 24, 2025 Filing ↗
Tony WiedTony WiedHouse · R · WI HIMSHims & Hers Health, Inc. · Stock Purchase
$15,001 - $50,000
Mar 14, 2025 Feb 25, 2025 Filing ↗

Whale Activity

Position changes in HIMS reported for 2026-09-30 by 559 institutional filers
Increased: 154New: 61Held: 76Decreased: 159Closed: 82No prior filing: 27
  • Increased154
  • New61
  • Held76
  • Decreased159
  • Closed82
  • No prior filing27
FilerSharesValueChange
BlackRock, Inc.29.7M$885.9Mincreased
VANGUARD PORTFOLIO MANAGEMENT LLC10.4M$310.1Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC9.5M$283.8Mdecreased
STATE STREET CORP8.2M$245.5Mincreased
Divisadero Street Capital Management, LP7.3M$218.8Mincreased
MORGAN STANLEY6.2M$185.9Mdecreased
GEODE CAPITAL MANAGEMENT, LLC5.6M$167.8Mdecreased
UBS Group AG4.8M$141.6Mincreased
FMR LLC4.7M$139.3Mincreased
JPMORGAN CHASE & CO4.8M$136.7Mdecreased
TWO SIGMA INVESTMENTS, LP4.4M$130.2Mnew
GOLDMAN SACHS GROUP INC3.9M$115.6Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by HIMS insiders, by quarter · Form 4
-2.0M-1.0M01.0M2.0M2025 Q1: -1.4M2025 Q12025 Q2: -831.6K2025 Q22025 Q3: -1.7M2025 Q32025 Q4: -298.6K2025 Q42026 Q1: -144.9K2026 Q12026 Q2: -201.0K2026 Q22026 Q3: -147.3K2026 Q32026 Q4: -39.7K2026 Q4

Recent Insider Transactions

1,425 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Okupe OluyemiChief Financial Officer Sale −3,518 $18.53 $65K Nov 17, 2026 Form 4 ↗
Autor Deborah M.Chief Policy Officer · Director Sale −23.8K $18.53 $442K Nov 17, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −3,458 $18.53 $64K Nov 17, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −3,462 $27.60 $96K Oct 28, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −3,461 $29.06 $101K Oct 14, 2026 Form 4 ↗
Okupe OluyemiChief Financial Officer Sale −2,000 $29.70 $59K Oct 1, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −3,461 $29.17 $101K Sep 30, 2026 Form 4 ↗
Okupe OluyemiChief Financial Officer Sale −29.3K $29.95 $877K Sep 22, 2026 Form 4 ↗
Okupe OluyemiChief Financial Officer Option exercise +14.0K $5.01 $70K Sep 22, 2026 Form 4 ↗
Okupe OluyemiChief Financial Officer Sale −12.3K $28.82 $355K Sep 17, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −6,236 $27.86 $174K Sep 16, 2026 Form 4 ↗
Elshenawy MohamedCTO Sale −7,954 $28.39 $226K Sep 15, 2026 Form 4 ↗
Chi MichaelChief Operating Officer Sale −14.0K $28.39 $398K Sep 15, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −3,458 $28.33 $98K Sep 2, 2026 Form 4 ↗
Dudum AndrewChief Executive Officer · Director · 10% owner Other −977.6K $0.00 $0 Aug 27, 2026 Form 4 ↗
Dudum AndrewChief Executive Officer · Director · 10% owner Gift −463.3K $0.00 $0 Aug 25, 2026 Form 4 ↗
Okupe OluyemiChief Financial Officer Sale −4,938 $29.99 $148K Aug 19, 2026 Form 4 ↗
Okupe OluyemiChief Financial Officer Option exercise +4,938 $5.01 $25K Aug 19, 2026 Form 4 ↗
Boughton SoleilChief Legal Officer Sale −25.1K $27.55 $692K Aug 19, 2026 Form 4 ↗
Autor Deborah M.Chief Policy Officer · Director Sale −16.8K $27.85 $467K Aug 18, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding HIMS · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Mid-Cap ETF
iShares Trust
7.3M$251.4M0.20%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
6.7M$232.8M0.01%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
5.5M$192.3M0.23%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
4.9M$168.6M0.09%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
2.8M$97.1M0.21%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.4M$84.4M0.09%Jun 30, 2026
iShares Russell 2000 Growth ETF
iShares Trust
2.0M$69.2M0.45%Jun 30, 2026
JPMorgan Large Cap Growth Fund
JPMorgan Trust II
2.0M$68.5M0.06%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
2.4M$65.6M0.19%Jul 31, 2026
State Street SPDR S&P MidCap 400SM ETF Trust
SPDR S&P MIDCAP 400 ETF TRUST
1.6M$56.5M0.20%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list HIMS's shares (CUSIP 433000106), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Susquehanna Securities, LLCSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
    Nov 16, 2026 · ↗
  • Susquehanna Investment GroupSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
    Nov 16, 2026 · ↗
  • SIG Brokerage, LPSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
    Nov 16, 2026 · ↗
  • G1 Execution Services, LLCSCHEDULE 13G/A · passive (13G) · 10.7M shares4.8%
    Nov 16, 2026 · ↗
  • Vanguard Capital ManagementSCHEDULE 13G/A · passive (13G) · 11.2M shares5.0%
    Oct 30, 2026 · ↗
  • Andrew DudumSCHEDULE 13D/A · activist (13D) · 22.6M shares9.4%
    Aug 31, 2026 · ↗
  • Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 11.2M shares5.0%
    Jul 31, 2026 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 26.5M shares11.9%
    Jul 28, 2026 · ↗
  • Susquehanna Securities, LLCSCHEDULE 13G · passive (13G) · 14.5M shares6.5%
    May 15, 2026 · ↗
  • Susquehanna Investment GroupSCHEDULE 13G · passive (13G) · 14.5M shares6.5%
    May 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming hims hers health as client
$0$1.3M$2.5M$3.8M$5.0M2023 Q4: $20K20232024 Q1: $80K2024 Q2: $80K2024 Q3: $100K2024 Q4: $50K20242025 Q1: $590K2025 Q2: $750K2025 Q3: $1.1M2025 Q4: $400K20252026 Q1: $480K2026 Q2: $400K2026 Q3: $370K2026
  • HIMS & HERS HEALTH, INC.HIMS & HERS HEALTH, INC. · 2026 Q3 · HCR$270K
    Filing ↗
  • CASSIDY & ASSOCIATES, INC.HIMS & HERS HEALTH, INC. · 2026 Q3 · HCR$40K
    Filing ↗
  • KOUNTOUPES DENHAM CARR & REID, LLCHIMS & HERS HEALTH, INC. · 2026 Q3 · HCR$60K
    Filing ↗
  • HIMS & HERS HEALTH, INC.HIMS & HERS HEALTH, INC. · 2026 Q2 · HCR$290K
    Filing ↗
  • CASSIDY & ASSOCIATES, INC.HIMS & HERS HEALTH, INC. · 2026 Q2 · HCR$50K
    Filing ↗

Government Contracts

Federal awards to Hims & Hers Health, Inc. · USAspending

No federal contract awards found for Hims & Hers Health, Inc..

U.S. Patents

Recent USPTO applications naming Hims & Hers Health, Inc.

No USPTO patent applications found for Hims & Hers Health, Inc..

Annual Financials

From HIMS's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$2.35B$1.48B$872.0M$526.9M$271.9M
Operating income$105.6M$61.9M-$29.5M-$68.7M-$115.0M
Net income$128.4M$126.0M-$23.5M-$65.7M-$107.7M
Diluted EPS$0.51$0.53-$0.11-$0.32-$0.58
Operating cash flow$300.0M$251.1M$73.5M-$26.5M-$34.4M
Cash and equivalents$228.6M$220.6M$96.7M$46.8M$71.8M
Total assets$2.15B$707.5M$441.2M$366.3M$420.6M
Total liabilities$1.61B$230.8M$97.2M$54.6M$86.0M
Shareholders' equity$540.9M$476.7M$344.0M$311.7M$334.6M

As Hims & Hers Health, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 23, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in HIMS's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02Officer / director changeNov 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsNov 9, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeOct 7, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 10, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeJul 17, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationJul 1, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 15, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 8.01, 9.01Material agreement · Direct financial obligation · Other eventsJun 2, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 3.02, 9.01Material agreement · Direct financial obligation · Unregistered sale of equityMay 21, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsMay 19, 2026
    EDGAR ↗

About Hims & Hers Health, Inc.

From SEC EDGAR company records
Industry (SIC 8011)Services-Offices & Clinics of Doctors of Medicine
SectorHealthcare
HeadquartersSAN FRANCISCO, CA
IncorporatedDE
Former namesOaktree Acquisition Corp.